JP2023011735A5 - - Google Patents

Download PDF

Info

Publication number
JP2023011735A5
JP2023011735A5 JP2022171542A JP2022171542A JP2023011735A5 JP 2023011735 A5 JP2023011735 A5 JP 2023011735A5 JP 2022171542 A JP2022171542 A JP 2022171542A JP 2022171542 A JP2022171542 A JP 2022171542A JP 2023011735 A5 JP2023011735 A5 JP 2023011735A5
Authority
JP
Japan
Prior art keywords
composition according
dry eye
trifluoromethylchroman
tetrahydronaphthalen
ylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022171542A
Other languages
English (en)
Japanese (ja)
Other versions
JP7801201B2 (ja
JP2023011735A (ja
Filing date
Publication date
Priority claimed from JP2022017196A external-priority patent/JP7248836B2/ja
Application filed filed Critical
Publication of JP2023011735A publication Critical patent/JP2023011735A/ja
Publication of JP2023011735A5 publication Critical patent/JP2023011735A5/ja
Priority to JP2026000075A priority Critical patent/JP2026042857A/ja
Application granted granted Critical
Publication of JP7801201B2 publication Critical patent/JP7801201B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022171542A 2019-10-04 2022-10-26 ヘテロシクリデンアセトアミド誘導体含有医薬 Active JP7801201B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000075A JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019184053 2019-10-04
JP2019184053 2019-10-04
JP2022017196A JP7248836B2 (ja) 2019-10-04 2022-02-07 ヘテロシクリデンアセトアミド誘導体含有医薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022017196A Division JP7248836B2 (ja) 2019-10-04 2022-02-07 ヘテロシクリデンアセトアミド誘導体含有医薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000075A Division JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Publications (3)

Publication Number Publication Date
JP2023011735A JP2023011735A (ja) 2023-01-24
JP2023011735A5 true JP2023011735A5 (https=) 2023-10-04
JP7801201B2 JP7801201B2 (ja) 2026-01-16

Family

ID=75338162

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021541679A Active JP7025094B2 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2022017196A Active JP7248836B2 (ja) 2019-10-04 2022-02-07 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2022171542A Active JP7801201B2 (ja) 2019-10-04 2022-10-26 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2026000075A Pending JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2021541679A Active JP7025094B2 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬
JP2022017196A Active JP7248836B2 (ja) 2019-10-04 2022-02-07 ヘテロシクリデンアセトアミド誘導体含有医薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026000075A Pending JP2026042857A (ja) 2019-10-04 2026-01-05 ヘテロシクリデンアセトアミド誘導体含有医薬

Country Status (17)

Country Link
US (2) US12533337B2 (https=)
EP (2) EP4545095A3 (https=)
JP (4) JP7025094B2 (https=)
KR (1) KR20220078604A (https=)
CN (1) CN114585357A (https=)
AU (1) AU2026202464A1 (https=)
BR (1) BR112022005992A2 (https=)
CA (1) CA3156484A1 (https=)
DK (1) DK4043014T3 (https=)
ES (1) ES3031607T3 (https=)
HU (1) HUE072085T2 (https=)
MX (2) MX2022004027A (https=)
MY (1) MY207759A (https=)
PH (1) PH12022550805A1 (https=)
PL (1) PL4043014T3 (https=)
PT (1) PT4043014T (https=)
WO (1) WO2021066144A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY207759A (en) 2019-10-04 2025-03-17 Mochida Pharm Co Ltd Pharmaceutical drug containing heterocyclidene acetamide derivative
CA3215750A1 (en) * 2021-03-30 2022-10-06 Senju Pharmaceutical Co., Ltd. Suspension containing heterocyclidene acetamide derivative
AU2023352013A1 (en) 2022-09-29 2025-04-03 Mochida Pharmaceutical Co., Ltd. Combination preparation containing heterocyclidene acetamide derivative
WO2024071348A1 (ja) 2022-09-29 2024-04-04 千寿製薬株式会社 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5621566A (en) 1979-08-01 1981-02-28 Alpha- Shokuhin Kk Preparation of bifun from homegrown rice and apparatus used for it
ZA200800959B (en) * 2005-07-22 2009-10-28 Mochida Pharmaceutical Company Novel heterocyclidene acetamide derivative
RU2451014C2 (ru) 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
NZ565080A (en) 2005-07-22 2011-03-31 Mochida Pharm Co Ltd Novel heterocyclidene acetamide derivative
TW200927192A (en) * 2007-11-19 2009-07-01 Alcon Res Ltd Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
US20100210682A1 (en) * 2009-02-19 2010-08-19 Abbott Laboratories Repeated Dosing of TRPV1 Antagonists
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
WO2012045729A1 (en) * 2010-10-05 2012-04-12 Glaxo Group Limited Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
GB201215857D0 (en) * 2012-09-05 2012-10-24 Sylentis Sau siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
JP6230743B1 (ja) * 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
JP7373909B2 (ja) 2018-04-06 2023-11-06 株式会社シマノ 変速制御装置および変速システム
MY207759A (en) 2019-10-04 2025-03-17 Mochida Pharm Co Ltd Pharmaceutical drug containing heterocyclidene acetamide derivative

Similar Documents

Publication Publication Date Title
JP2023011735A5 (https=)
JP2022065024A5 (https=)
JP2023017050A5 (https=)
JP2021515758A5 (https=)
JP2014525426A5 (https=)
JP2010280708A5 (https=)
SA522433000B1 (ar) مركبات فلورو ألكيل-أوكساديازول واستخداماتها
JP2019137703A5 (https=)
JP2012520249A5 (https=)
IL263314A (en) Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
JP2018035160A5 (https=)
JP2023098936A5 (https=)
JP2014502979A5 (https=)
JP2017528507A5 (https=)
JP2014062126A5 (https=)
JP2020138980A5 (https=)
JP2013544786A5 (https=)
JP2010516702A5 (https=)
JP2014533274A5 (https=)
MX2021010133A (es) Forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifl uorometil)-n-(2-(trifluorometil)piridin-4-il)-1h-pirazol-4-carbox amida monohidratada.
JP2019519533A5 (https=)
JP2020514283A5 (https=)
JP2017522300A5 (https=)
RU2017116974A (ru) Офтальмологическая композиция, содержащая циклоспорин и трегалозу
JPWO2023195530A5 (https=)